Additionally, the study examines the expression and interactions of key immune regulatory markers, including CD244, CD48, FOXD3, and PVRL2, to provide a comprehensive understanding of the immune landscape in B-ALL. This evidence concerns the gene FOXD3 and acute lymphoblastic leukemia.